BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9272979)

  • 1. [Risk factors and breast carcinoma: our experience in a department of senology].
    Galati G; Cangemi V; Martinazzoli A; Fiori E; Boccuzzi M; Rengo M
    G Chir; 1996; 17(6-7):353-7. PubMed ID: 9272979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of hormone replacement therapy on the histologic subtype of breast cancer.
    Zanetti-Dällenbach RA; Krause EM; Lapaire O; Gueth U; Holzgreve W; Wight E
    Arch Gynecol Obstet; 2008 Nov; 278(5):443-9. PubMed ID: 18335229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A population-based study of bilateral prophylactic mastectomy efficacy in women at elevated risk for breast cancer in community practices.
    Geiger AM; Yu O; Herrinton LJ; Barlow WE; Harris EL; Rolnick S; Barton MB; Elmore JG; Fletcher SW
    Arch Intern Med; 2005 Mar; 165(5):516-20. PubMed ID: 15767526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and risk factors associated with bilateral breast cancer in area with early age diagnosis but low incidence of primary breast cancer: analysis of 10-year longitudinal cohort in Taiwan.
    Kuo WH; Yen AM; Lee PH; Hou MF; Chen SC; Chen KM; Chen TH; Chang KJ
    Breast Cancer Res Treat; 2006 Sep; 99(2):221-8. PubMed ID: 16544057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High risk of contralateral breast carcinoma in women with hereditary/familial non-BRCA1/BRCA2 breast carcinoma.
    Shahedi K; Emanuelsson M; Wiklund F; Gronberg H
    Cancer; 2006 Mar; 106(6):1237-42. PubMed ID: 16475207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early breast cancer detection.
    Foti E; Mancuso S
    Minerva Ginecol; 2005 Jun; 57(3):269-92. PubMed ID: 16166936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
    Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
    Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of invasive breast cancer and ductal carcinoma in situ in a screening program by age: should older women continue screening?
    Erbas B; Amos A; Fletcher A; Kavanagh AM; Gertig DM
    Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1569-73. PubMed ID: 15466971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk for contralateral breast cancers in a population covered by mammography: effects of family history, age at diagnosis and histology.
    Ji J; Hemminki K
    Breast Cancer Res Treat; 2007 Oct; 105(2):229-36. PubMed ID: 17115107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mammography and prevention of breast carcinoma. Epidemiological considerations concerning female population of a Rome district].
    Cruciani P; Sonnino A; Biagi L; Casile S; Mancini R; Gigli M
    Recenti Prog Med; 1999; 90(7-8):383-6. PubMed ID: 10429517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast magnetic resonance image screening and ductal lavage in women at high genetic risk for breast carcinoma.
    Hartman AR; Daniel BL; Kurian AW; Mills MA; Nowels KW; Dirbas FM; Kingham KE; Chun NM; Herfkens RJ; Ford JM; Plevritis SK
    Cancer; 2004 Feb; 100(3):479-89. PubMed ID: 14745863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between bone mass, invasive breast cancer incidence and raloxifene therapy in postmenopausal women with low bone mass or osteoporosis.
    Burshell AL; Song J; Dowsett SA; Mershon JL; Delmas PD; Secrest RJ; Cauley JA
    Curr Med Res Opin; 2008 Mar; 24(3):807-13. PubMed ID: 18254988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of contralateral breast cancer.
    Chen Y; Thompson W; Semenciw R; Mao Y
    Cancer Epidemiol Biomarkers Prev; 1999 Oct; 8(10):855-61. PubMed ID: 10548312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ductal carcinoma in situ of the breast.
    Anderson WF; Chu KC
    N Engl J Med; 2004 Jul; 351(4):399-402; author reply 399-402. PubMed ID: 15278958
    [No Abstract]   [Full Text] [Related]  

  • 16. Twenty-year incidence and patterns of contralateral breast cancer after breast conservation treatment with radiation.
    Hill-Kayser CE; Harris EE; Hwang WT; Solin LJ
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1313-9. PubMed ID: 16997501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for breast cancer with MRI: recent experience from the Australian Capital Territory.
    Price J; Chen SW
    J Med Imaging Radiat Oncol; 2009 Feb; 53(1):69-80. PubMed ID: 19453531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma.
    Anderson WF; Chu KC; Chang S; Sherman ME
    Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1128-35. PubMed ID: 15247123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing incidence rate of invasive lobular breast carcinoma among older women.
    Li CI; Anderson BO; Porter P; Holt SK; Daling JR; Moe RE
    Cancer; 2000 Jun; 88(11):2561-9. PubMed ID: 10861434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial breast carcinoma risks by morphology: a nationwide epidemiologic study from Sweden.
    Hemminki K; Granström C
    Cancer; 2002 Jun; 94(11):3063-70. PubMed ID: 12115398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.